You are now leaving Kedrion Corporate site. Medical information including licensed uses may be different outside of the EU countries.
NO
YES

HIGHLIGHTS

News Highlight Thumbnail -  Kedrion Biopharma strengthens its presence in Russia

CORPORATE

Kedrion Biopharma strengthens its presence in Russia

Memorandum of Understanding with Russian pharmaceutical companies for a joint plasma products manufacturing program

read more 

PLASMA & BIOTHERAPIES

FDA Acceptance of BLA Submission for Human Rabies Immunoglobulin

Announcement by Kedrion Biopharma and Kamada. Regulatory decision expected in August 2017

read more 

EVENTS

Kedrion took part in the 17th ESID Meeting with 44 international guests

The conference focused on new insights into PIDs’ diagnosis and therapies

read more 
For more information please contact: pressoffice@kedrion.com